跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BANEOCIN POWDER - HSA Drug Approval Details
Approvals
/
HSA
/
BANEOCIN POWDER
Approved
THERAPEUTIC
BANEOCIN POWDER
PHARMAZEUTISCHE FABRIK MONTAVIT GESMBH (AUSTRIA)
🇸🇬 Health Sciences Authority
Approval Date
May 3, 1988
Approval ID
14ce8dc1d28fca9d
Company
PHARMAZEUTISCHE FABRIK MONTAVIT GESMBH (AUSTRIA)
Type
Therapeutic
Approval Details
Approval Id
14ce8dc1d28fca9d
Drug Name
BANEOCIN POWDER
Product Name
BANEOCIN POWDER
Approval Number
SIN00678P
Approval Date
1988-05-03
Registrant
SANDOZ SINGAPORE PTE. LTD.
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
POWDER
Route Of Administration
TOPICAL
Atc Code
D06AX04
Atc Item Name
neomycin
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Active Ingredients
BACITRACIN ZINC
250 iu/g
NEOMYCIN SULPHATE EQV NEOMYCIN
5000 iu/g
BACITRACIN ZINC
250 INTERNATIONAL UNITS/G
NEOMYCIN SULPHATE EQV NEOMYCIN
5,000 INTERNATIONAL UNITS/G
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 3, 1988
Approval ID
14ce8dc1d28fca9d
Type
Therapeutic
Back to HSA Approvals